ASP Isotopes Inc.
No SEC Form 4 filings for $ASPI in the last 30 days.
ASP Isotopes said Tetra4, a subsidiary of Renergen, signed a five-year take-or-pay LNG offtake for its Virginia Gas Project in South Africa. The deal covers about 10% of Phase 1 capacity, priced above $16 per GJ, and supports revenue certainty. Phase 1 targets ~2,500 GJ/day LNG and ~70 Mcf/day helium, with operations in Q3 2026; Phase 1 revenue could exceed $27M annually.
ASP Isotopes (ASPI) said group revenues are rising and three business units are nearing profitability inflection points ahead of its Q2 results. CEO Paul Mann cited PET Labs’ >50% organic revenue growth in H1 and forecast $14m full-year revenue (from $6m in 2025). ASPI reiterated its 2031 EBITDA target >$300m, with $330m to $700m expected, supported by long-term take-or-pay helium and LNG contracts via Renergen.
ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 aspi-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 ASP Isotopes Issues Letter to Shareholders DALLAS, August 4, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes”, “ASPI” or the “Company”), an advanced materials company focused on developing technologie
Over the past 7 days, alphai's AI scored 4 news stories mentioning ASPI (ASP Isotopes Inc.). Coverage has skewed bullish: 4 bullish, 0 neutral, and 0 bearish.
Recent ASPI coverage spans financial news, mergers & acquisitions and corporate actions.
The contract adds contracted LNG demand and supports Phase 1 revenue visibility, with potential positive sentiment for project financing and execution.
Management update increases confidence in near-term revenue and EBITDA ramp, especially from PET Labs growth and Renergen helium/LNG take-or-pay visibility.
The filing is a forward-looking operational roadmap that could re-rate ASPI’s probability-weighted path to profitability, especially around helium supply and isotope shipments.
The restart and target-level operation are a near-term execution catalyst that can change revenue timing and risk perception for ASPI’s isotope supply contracts.
Near-term catalyst is September start of deliveries and higher contracted pricing, supporting revenue visibility but execution risk remains.
alphai scores every news story that mentions ASPI with an AI model for sentiment and relevance, and aggregates insider trades from ASP Isotopes Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
ASP Isotopes said Tetra4, a subsidiary of Renergen, signed a five-year take-or-pay LNG offtake for its Virginia Gas Project in South Africa. The deal covers about 10% of Phase 1 capacity, priced above $16 per GJ, and supports revenue certainty. Phase 1 targets ~2,500 GJ/day LNG and ~70 Mcf/day helium, with operations in Q3 2026; Phase 1 revenue could exceed $27M annually.
6 min readASP Isotopes (ASPI) said group revenues are rising and three business units are nearing profitability inflection points ahead of its Q2 results. CEO Paul Mann cited PET Labs’ >50% organic revenue growth in H1 and forecast $14m full-year revenue (from $6m in 2025). ASPI reiterated its 2031 EBITDA target >$300m, with $330m to $700m expected, supported by long-term take-or-pay helium and LNG contracts via Renergen.
3 min readASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 aspi-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 ASP Isotopes Issues Letter to Shareholders DALLAS, August 4, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes”, “ASPI” or the “Company”), an advanced materials company focused on developing technologie
5 min readASP Isotopes (ASPI) said it restarted its Silicon-28 silicon enrichment facility in South Africa after nearly a year of optimization to meet customer expectations. The company reported the first 18 stages have operated for over three weeks at target enrichment levels and expects to fulfill U.S. supply agreements in Q3. ASPI shares rose more than 24% Tuesday.
3 min readASP Isotopes said it expects commercial helium deliveries from its South African project to start in September, as semiconductor demand rises and supply disruptions in Qatar and Russia push chipmakers to diversify. CEO Paul Mann expects phase 1 to reach nameplate capacity in Q3. The company’s first commercial offtake is priced above $600 per thousand cubic feet, up from about $400 a year ago.
5 min readASP Isotopes said its Quantum Leap Energy unit signed a research agreement with Texas A&M Engineering Experiment Station to collect data for converting uranium concentrate (U3O8) into uranium hexafluoride (UF6). The work is aimed at de-risking and supporting process design, modeling, scale-up, and commercialization of QLE conversion technology, amid limited US conversion capacity.
4 min readASP Isotopes (NASDAQ:ASPI) and ENDRA Life Sciences (NASDAQ:NDRA) said RedChip will host a July 21, 2026 webinar on Noble Africa, an ASP Isotopes subsidiary holding Renergen’s Virginia Gas Project. The proposed merger with ENDRA could list Noble Africa on Nasdaq as NOBA. CEO Paul Mann will discuss helium and LNG plans, including Phase 1 ramp in 2026.
2 min readASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 aspi_ex101.htm FORM OF SECURITIES EXCHANGE AGREEMENT aspi_ex101.htm EXHIBIT 10.1 FORM OF SECURITIES EXCHANGE AGREEMENT This Securities Exchange Agreement (this “ Agreement ”), dated as of July 15, 2026 (the “ Effective Date ”), is entered into by and between ASP Isotope
2 min readASP Isotopes (NASDAQ: ASPI) said it entered private exchange agreements with holders of Quantum Leap Energy LLC’s QLE convertible promissory notes. Holders will exchange about $109.2 million of notes plus accrued interest for about 23.2 million ASPI shares, about 17.8% of ASPI’s shares. The deal cuts QLE notes by about 50% to $110.7 million, expected to close July 16, 2026.
4 min readASP Isotopes (JSE, Nasdaq) said its wholly owned subsidiary Noble Africa will merge with a subsidiary of ENDRA Life Sciences, with Noble Africa as the surviving entity. The combined company plans to trade on Nasdaq as “Noble Africa Inc” under ticker NOBA. A private placement is expected to raise about $50m gross, including ~$20m from ASP Isotopes. ASP Isotopes expects ~89% ownership; deal expected Q3/Q4 pending SEC registration and approvals.
4 min read
